Compound ID | 1868
Class: Beta-lactam (carbapenem)
Spectrum of activity: | Gram-negative |
Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Carbapenems bind to all PBPs, with PBP2 and PBP4 as the highest-affinity targets |
Description: | Semisynthetic, derived from thienamycin, similar to ertapenem; clinical development only for China |
Institute where first reported: | Sihuan Pharmaceutical |
Year first mentioned: | 2015 |
Highest developmental phase: | Phase 3 (NCT04505683) |
Development status: | Active (as of 2022) |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/58326208 |
Guide to Pharmacology: | benapenem |
Citation: | https://journals.asm.org/doi/10.1128/AAC.02188-18 |